Amlodipine Cost in Pennsylvania 2026

What Is Amlodipine and Why Does Cost Matter?

Amlodipine is a long-acting dihydropyridine calcium channel blocker approved by the FDA for hypertension and angina. The FDA-approved prescribing information lists hypertension, chronic stable angina, and vasospastic (Prinzmetal) angina as indications [1]. Because nearly 1 in 3 American adults has hypertension, according to CDC surveillance data [2], amlodipine ranks among the most prescribed drugs in the United States. Cost barriers that prevent adherence carry real cardiovascular risk.

Pfizer launched the original brand, Norvasc, in 1992. Generic amlodipine besylate entered the U.S. market in 2000, and today the cash-pay generic price sits well below $10 per month at most Pennsylvania pharmacies. Still, patients who rely on brand prescriptions, lack insurance, or need specialized formulations face meaningfully different price points, so understanding each option is worth doing carefully.

The landmark ASCOT-BPLA trial (N=19,257) published in The Lancet in 2005 showed that an amlodipine-based regimen reduced the primary endpoint of nonfatal myocardial infarction and fatal coronary heart disease by 10% compared with an atenolol-based regimen (hazard ratio 0.90 to 95% CI 0.79, 1.02), with statistically significant reductions in total stroke (23%), total cardiovascular events (16%), and all-cause mortality (11%) [3]. These data cemented amlodipine as a first-line antihypertensive in U.S. and international guidelines.

The Eighth Joint National Committee (JNC 8) guideline specifically recommends thiazide diuretics, ACE inhibitors, ARBs, or calcium channel blockers as first-line therapy for most adult patients with hypertension [4]. Amlodipine satisfies that recommendation and appears on every major formulary as a result.

Generic Amlodipine Cash Price in Pennsylvania

Generic amlodipine costs approximately $8 per month at Pennsylvania retail pharmacies in 2026 for a standard 30-tablet supply of 5 mg or 10 mg. Prices span roughly $4 to $18 depending on chain, independent pharmacy, and whether the patient uses a discount card.

Major Pennsylvania pharmacy chains including Rite Aid, CVS, and Giant Food Stores routinely participate in GoodRx and similar programs. Applying a free GoodRx coupon typically brings a 30-tablet supply of generic amlodipine 5 mg to $6 to $9 at Pennsylvania zip codes. Walmart's $4 generics program includes amlodipine in Pennsylvania, making it one of the lowest cash-pay options in the state. The FDA defines a generic drug as bioequivalent to its reference listed drug within accepted pharmacokinetic limits [5], so patients pay less without sacrificing therapeutic equivalence.

Pill-splitting is a practical cost strategy for patients on 5 mg who could be prescribed 10 mg tablets instead. Amlodipine tablets are scored, and the FDA's guidance on tablet splitting acknowledges that splitting can be appropriate when the tablet is designed for it [6]. A prescriber must authorize the change, but the math is straightforward: one 10 mg tablet split into two 5 mg doses halves the per-dose cost.

Brand-Name Norvasc Price in Pennsylvania

The Pfizer brand Norvasc carries a manufacturer list price of approximately $80 per month for a 30-tablet supply. Without insurance or a savings card, a Pennsylvania patient paying cash for brand Norvasc spends roughly 10 times more than a patient buying generic amlodipine.

Pfizer offers a Norvasc savings card for commercially insured patients. Eligible patients may pay as little as $4 per month using the card, but it explicitly excludes patients enrolled in Medicaid, Medicare, or any other federal or state government program [7]. Pennsylvania residents on Medical Assistance (PA Medicaid) or Medicare Part D cannot legally use the Pfizer savings card. For those patients, the generic is almost always the financially correct choice.

Pharmacists in Pennsylvania are legally permitted to substitute a generic equivalent unless the prescriber writes "dispense as written" or "DAW" on the prescription. Most prescribers use the generic by default for amlodipine given the cost difference and demonstrated bioequivalence.

Pennsylvania Medicaid (Medical Assistance) Coverage

Pennsylvania Medicaid covers generic amlodipine for enrolled adults with hypertension or angina. The Pennsylvania Department of Human Services manages the Medical Assistance program, and amlodipine appears on the Pennsylvania Preferred Drug List (PDL) as a preferred calcium channel blocker [8].

Preferred status means that most Medicaid managed care organizations (MCOs) in Pennsylvania cover generic amlodipine at the lowest cost-sharing tier, often $0 to $1 copay per 30-day fill for eligible enrollees. The Centers for Medicare and Medicaid Services (CMS) requires that state Medicaid programs cover outpatient drugs from manufacturers who sign rebate agreements, and virtually all generic amlodipine manufacturers participate [9].

Pennsylvania expanded Medicaid under the Affordable Care Act, and as of 2024 more than 3.5 million Pennsylvanians were enrolled in Medical Assistance or CHIP, per CMS enrollment data [10]. Adults earning up to 138% of the federal poverty level qualify. A single adult earning up to approximately $20,783 per year in 2026 is likely eligible.

Prior authorization is not typically required for generic amlodipine under Pennsylvania Medicaid for hypertension. Brand Norvasc would require a prior authorization demonstrating medical necessity and failure of the generic, which is rarely granted given bioequivalence.

Insurance Coverage and Formulary Tiers in Pennsylvania

Most commercial insurance plans sold through the Pennsylvania Health Insurance Exchange (Pennie) or employer-sponsored coverage place generic amlodipine on Tier 1, the lowest-cost formulary tier. Tier 1 copays in Pennsylvania plans typically range from $0 to $15 per 30-day supply.

The Affordable Care Act requires that plans cover preventive medications with a USPSTF grade A or B recommendation at no cost-sharing. The USPSTF recommends initiating statin use for primary prevention of cardiovascular disease in certain adults [11], but amlodipine itself is prescribed for treatment rather than purely for primary prevention, so the zero-cost-sharing mandate does not automatically apply to amlodipine in the same way. Patients should verify their specific plan's tier placement before assuming zero cost-sharing.

Medicare Part D beneficiaries in Pennsylvania face more variability. Each Part D plan maintains its own formulary. The Centers for Medicare and Medicaid Services requires all Part D plans to cover at least two drugs in every therapeutic class [12], so every Part D plan sold in Pennsylvania must include at least one calcium channel blocker. Generic amlodipine appears on almost every Part D plan's formulary as a Tier 1 or Tier 2 drug. Copays average $0 to $10 per month for Tier 1 placement. Patients in the catastrophic coverage phase of Part D pay no more than 25% of drug costs after 2024 changes under the Inflation Reduction Act [13].

The Extra Help (Low Income Subsidy) program through Social Security reduces or eliminates Part D cost-sharing for qualifying Medicare beneficiaries. Pennsylvania residents earning up to 150% of the federal poverty level may qualify for full Extra Help, bringing amlodipine cost to $0 to $4 per month [14].

Compounded Amlodipine in Pennsylvania: Legality and Cost

Compounded amlodipine is legal in Pennsylvania when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies and allows them to prepare customized formulations that are not commercially available or that serve a documented clinical need for an individual patient [15].

Pennsylvania's State Board of Pharmacy licenses 503A compounding pharmacies and enforces USP <795> and USP <797> standards for non-sterile and sterile compounding, respectively. Amlodipine is commercially available as an oral tablet, so a prescriber ordering compounded amlodipine must document a clinical reason, such as a patient who cannot swallow tablets and requires an oral suspension, or an allergy to a tablet excipient.

Compounded amlodipine oral suspension from a 503A pharmacy may cost $0 per month for patients whose insurance covers compounded medications, or a nominal dispensing fee of $15 to $40 per month cash-pay, depending on the pharmacy. That figure is lower than generic retail in some cases when insurance applies.

Pennsylvania does not have a list of 503B outsourcing facilities within the state for amlodipine specifically, because amlodipine is not a drug in shortage and is not on FDA's 503B drug shortage list [16]. Compounding from a 503B outsourcing facility without a patient-specific prescription for a non-shortage drug is not legally permitted under federal law.

Telehealth Prescribing of Amlodipine in Pennsylvania

Pennsylvania permits telehealth prescribing of amlodipine. The Pennsylvania Telemedicine Act (Act 21 of 2020) authorizes licensed practitioners to establish a patient-provider relationship and prescribe medications via synchronous audio-visual telehealth without a prior in-person visit, provided they meet the standard of care [17].

Amlodipine is not a controlled substance, so the DEA's special telehealth prescribing rules for Schedule II through V drugs do not apply. A Pennsylvania-licensed physician, CRNP, or PA-C can issue a new prescription for amlodipine after a telehealth visit that includes a blood pressure assessment (using a patient's home blood pressure monitor or a recently documented office reading).

Telehealth platforms that prescribe amlodipine in Pennsylvania typically charge $50 to $99 for an initial visit and $30 to $59 for follow-up visits, though many insurance plans cover telehealth visits at the same cost-sharing as in-person visits under Pennsylvania's telehealth parity law [18]. Patients combining a telehealth visit with a $8 generic prescription and a GoodRx coupon may achieve total first-month costs under $60, which is competitive with or lower than a traditional office visit copay plus pharmacy copay.

Pennsylvania Amlodipine Discount Programs

Several discount programs reduce amlodipine costs for Pennsylvania residents who do not qualify for Medicaid or who have high-deductible insurance.

GoodRx provides free coupons accepted at most Pennsylvania pharmacies. Prices vary by zip code, but 30 tablets of amlodipine 5 mg typically fall between $6 and $9 statewide with a GoodRx coupon applied [19]. GoodRx is not insurance; it is a pharmacy benefit manager-negotiated discount that the patient presents at the counter.

NeedyMeds maintains a database of patient assistance programs and discount options organized by state. Pennsylvania residents earning below 200% to 400% of the federal poverty level may qualify for manufacturer patient assistance programs (PAPs) from branded drug manufacturers, though Pfizer's Norvasc PAP has limited applicability given generic availability [20].

The Pennsylvania PACE and PACENET programs provide prescription assistance to older Pennsylvania residents. PACE (Pharmaceutical Assistance Contract for the Elderly) covers residents age 65 and older with annual income at or below $14,500 (single) or $17,700 (married). PACENET covers those with income up to $27,500 (single) or $33,500 (married). Amlodipine is covered under both programs, and copays are capped at $6 to $9 per prescription [21].

RxAssist and the Partnership for Prescription Assistance also maintain searchable databases of free or low-cost medication programs available to Pennsylvania residents. These programs are separate from Medicaid and do not require Medicaid enrollment.

How Amlodipine Is Dosed and Why That Affects Cost

Amlodipine is prescribed as a once-daily oral tablet in doses of 2.5 mg, 5 mg, or 10 mg. The FDA-approved label for amlodipine besylate states that the usual starting dose for hypertension in adults is 5 mg once daily, with a maximum dose of 10 mg once daily [1]. Smaller patients, elderly patients, and those with hepatic impairment may start at 2.5 mg.

Cost scales with tablet count, not with dose strength. A 30-count supply of 2.5 mg, 5 mg, or 10 mg generic amlodipine typically costs the same at most Pennsylvania pharmacies, roughly $6 to $9 with a discount card. Prescribing a 90-day supply instead of a 30-day supply often reduces the per-tablet cost further, and mail-order pharmacy programs through Pennsylvania insurance plans typically offer 90-day supplies at 2.5 times the 30-day copay, effectively providing 30 days free.

Hypertension guidelines from the American Heart Association and American College of Cardiology (2017 ACC/AHA Hypertension Guideline) define stage 1 hypertension as a systolic blood pressure of 130 to 139 mm Hg or diastolic of 80 to 89 mm Hg, and stage 2 as 140/90 mm Hg or higher [22]. Patients with stage 2 hypertension often require combination therapy, and fixed-dose combination products containing amlodipine (such as amlodipine/benazepril or amlodipine/valsartan) are available generically at modestly higher prices, typically $15 to $25 per month, still well below brand-name alternatives.

Safety, Side Effects, and Adherence Context

Cost conversations about amlodipine cannot be separated from adherence, because patients who stop taking antihypertensives due to cost face measurable cardiovascular risk. A 2019 analysis published in the Journal of the American College of Cardiology found that medication non-adherence among hypertensive patients was associated with a 3.81-fold increased risk of cardiovascular events compared with adherent patients [23]. Amlodipine's once-daily dosing and long half-life of 30 to 50 hours [1] make it more forgiving of missed doses than shorter-acting agents, which may support adherence.

Common side effects include peripheral edema (affecting up to 10.8% of patients on 10 mg per the FDA label), flushing, and palpitations [1]. Edema is dose-dependent and may resolve with dose reduction or addition of an ACE inhibitor or ARB. Gingival hyperplasia is a rare but documented adverse effect of calcium channel blockers, occurring more often with nifedipine than amlodipine but reported at low frequency with amlodipine as well [24].

Drug interactions relevant to cost-conscious patients include simvastatin: the FDA limits simvastatin dosing to 20 mg per day when co-administered with amlodipine due to increased simvastatin exposure [25]. Patients on higher-dose simvastatin may need to switch to rosuvastatin or pravastatin, which affects overall medication costs. Prescribers managing amlodipine therapy should review the full interaction profile.

Practical Step-by-Step Cost Reduction for Pennsylvania Patients

Pennsylvania patients paying too much for amlodipine can work through a structured sequence. First, confirm the prescription is written for the generic (amlodipine besylate, not Norvasc) and that no "dispense as written" instruction appears. Second, run the prescription through GoodRx or RxSaver before paying, comparing prices across nearby pharmacies. Third, ask the pharmacist about a 90-day supply, which reduces per-tablet cost at most chains. Fourth, if income qualifies, apply for PA PACE or PACENET through the Pennsylvania Department of Aging, which caps copays at $6 to $9 per fill [21]. Fifth, patients under 65 below 138% of the federal poverty level should check Medicaid eligibility through Pennsylvania's COMPASS system. Sixth, patients with commercial insurance in a deductible period should apply the GoodRx coupon directly rather than running through insurance, because GoodRx prices often beat the pre-deductible insurance cash price.

A telehealth visit is a valid and legal route to an initial amlodipine prescription in Pennsylvania and costs less than many specialist co-pays. Blood pressure measured on a validated home monitor at three separate readings provides sufficient clinical data for a prescriber to initiate or continue amlodipine under current Pennsylvania telehealth standards.

Monitoring Requirements That Affect Total Cost of Care

Amlodipine therapy requires periodic blood pressure monitoring and a baseline metabolic panel. The 2017 ACC/AHA guideline recommends reassessing blood pressure one month after initiating or changing therapy [22]. Patients using home monitors can report readings via patient portals or telehealth check-ins, reducing in-office visit costs. The American Heart Association recommends validated upper-arm automated oscillometric devices for home blood pressure monitoring [26].

Renal function monitoring is not specifically required for amlodipine alone, unlike ACE inhibitors or ARBs, which reduces ancillary laboratory costs. Liver function testing may be considered at baseline in patients with suspected hepatic impairment, since amlodipine is extensively hepatically metabolized (CYP3A4) and half-life is prolonged in hepatic disease [1]. Otherwise, amlodipine has a favorable monitoring burden compared with other antihypertensives, which contributes to lower total cost of care.